Variant report

Variant	esv19841
Chromosome Location	chr5:1631508-1636570
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:669)
CpG islands
(count:671)
Chromatin interactive
region (count:13)
LncRNA
region (count:1)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:669 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF1	chr5:1633962-1634337	K562	blood:	n/a	n/a
2	ATF2	chr5:1633966-1634208	H1-hESC	embryonic stem cell:	n/a	n/a
3	ATF2	chr5:1633852-1634334	GM12878	blood:	n/a	n/a
4	ATF3	chr5:1633905-1634255	K562	blood:	n/a	n/a
5	ATF3	chr5:1633974-1634418	H1-hESC	embryonic stem cell:	n/a	n/a
6	ATF3	chr5:1633901-1634276	A549	lung:	n/a	n/a
7	ATF3	chr5:1633984-1634262	HepG2	liver:	n/a	n/a
8	BATF	chr5:1635467-1636215	GM12878	blood:	n/a	n/a
9	BATF	chr5:1635405-1636089	GM12878	blood:	n/a	n/a
10	BCL11A	chr5:1633938-1634313	GM12878	blood:	n/a	chr5:1634124-1634133
11	BCL11A	chr5:1635428-1636092	GM12878	blood:	n/a	chr5:1635788-1635797 chr5:1635787-1635796
12	BCL11A	chr5:1631500-1631839	GM12878	blood:	n/a	n/a
13	BCL11A	chr5:1633373-1633588	GM12878	blood:	n/a	chr5:1633383-1633392
14	BCL11A	chr5:1633321-1633560	GM12878	blood:	n/a	chr5:1633383-1633392
15	BCL11A	chr5:1635660-1636035	GM12878	blood:	n/a	chr5:1635788-1635797 chr5:1635787-1635796
16	BCL3	chr5:1633865-1634445	A549	lung:	n/a	chr5:1634124-1634133
17	BCL3	chr5:1633888-1634279	A549	lung:	n/a	chr5:1634124-1634133
18	BCLAF1	chr5:1633838-1634367	GM12878	blood:	n/a	chr5:1634124-1634133
19	BCLAF1	chr5:1633890-1634324	GM12878	blood:	n/a	chr5:1634124-1634133
20	BHLHE40	chr5:1633951-1634300	K562	blood:	n/a	n/a
21	BHLHE40	chr5:1633967-1634356	GM12878	blood:	n/a	n/a
22	BRCA1	chr5:1633946-1634304	Hela-S3	cervix:	n/a	n/a
23	CBX3	chr5:1633881-1634472	K562	blood:	n/a	n/a
24	CCNT2	chr5:1633874-1634337	K562	blood:	n/a	n/a
25	CEBPB	chr5:1633912-1634412	K562	blood:	n/a	n/a
26	CEBPB	chr5:1634004-1634336	Hela-S3	cervix:	n/a	n/a
27	CEBPD	chr5:1633874-1634390	K562	blood:	n/a	n/a
28	CEBPD	chr5:1633894-1634373	HepG2	liver:	n/a	n/a
29	CHD1	chr5:1633920-1634532	GM12878	blood:	n/a	n/a
30	CHD2	chr5:1633916-1634316	GM12878	blood:	n/a	n/a
31	CHD2	chr5:1633878-1634311	Hela-S3	cervix:	n/a	n/a
32	CHD2	chr5:1633995-1634369	H1-hESC	embryonic stem cell:	n/a	n/a
33	CHD2	chr5:1633973-1634252	HepG2	liver:	n/a	n/a
34	CHD2	chr5:1633943-1634342	K562	blood:	n/a	n/a
35	CREB1	chr5:1633900-1634387	GM12878	blood:	n/a	n/a
36	CREB1	chr5:1633861-1634458	H1-hESC	embryonic stem cell:	n/a	n/a
37	CREB1	chr5:1633810-1634397	A549	lung:	n/a	n/a
38	CREB1	chr5:1633967-1634253	A549	lung:	n/a	n/a
39	CREB1	chr5:1633837-1634441	HepG2	liver:	n/a	n/a
40	CREB1	chr5:1633814-1634489	HepG2	liver:	n/a	n/a
41	CREB1	chr5:1633823-1634422	H1-hESC	embryonic stem cell:	n/a	n/a
42	CREB1	chr5:1633882-1634549	GM12878	blood:	n/a	n/a
43	CREB1	chr5:1633841-1634452	K562	blood:	n/a	n/a
44	CREB1	chr5:1633834-1634434	K562	blood:	n/a	n/a
45	CTBP2	chr5:1634003-1634301	H1-hESC	embryonic stem cell:	n/a	n/a
46	CTCF	chr5:1634100-1634250	AG04449	skin:	n/a	n/a
47	CTCF	chr5:1634088-1634098	K562	blood:	n/a	n/a
48	CTCF	chr5:1634100-1634250	SK-N-SH_RA	brain:	n/a	n/a
49	CTCF	chr5:1633558-1633566	GM13976	blood:	n/a	n/a
50	CTCF	chr5:1634000-1634150	K562	blood:	n/a	n/a

(count:671 , 50 per page) page: 1 2 3 4 5 6 7 ... 14

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr5:1635186-1635236	GM06990	blood:	n/a
2	chr5:1635186-1635236	AG04449	skin:	fetal
3	chr5:1634147-1634197	HIPEpiC	eye:	n/a
4	chr5:1634460-1634510	NHBE	bronchial:	n/a
5	chr5:1634505-1634555	HCT-116	colon:	n/a
6	chr5:1633830-1633880	HRCEpiC	kidney:	n/a
7	chr5:1633398-1633448	GM06990	blood:	n/a
8	chr5:1632226-1632276	IMR90	lung:	fetal
9	chr5:1634049-1634099	HNPCEpiC	eye:	n/a
10	chr5:1633907-1633957	GM12891	blood:	n/a
11	chr5:1634502-1634552	SK-N-MC	brain:	n/a
12	chr5:1634460-1634510	SKMC	muscle:	n/a
13	chr5:1633830-1633880	Hepatocyte	liver:	n/a
14	chr5:1633907-1633957	IMR90	lung:	fetal
15	chr5:1633830-1633880	HCF	heart:	n/a
16	chr5:1634049-1634099	CMK	blood:	n/a
17	chr5:1633830-1633880	NHBE	bronchial:	n/a
18	chr5:1633830-1633880	BJ	skin:	n/a
19	chr5:1633907-1633957	GM12892	blood:	n/a
20	chr5:1634049-1634099	AG10803	skin:	n/a
21	chr5:1634218-1634268	Hepatocyte	liver:	n/a
22	chr5:1634460-1634510	ovcar-3	ovarian:	n/a
23	chr5:1633398-1633448	HCM	heart:	n/a
24	chr5:1633907-1633957	PANC-1	pancreas:	n/a
25	chr5:1633398-1633448	PANC-1	pancreas:	n/a
26	chr5:1634049-1634099	HAEpiC	amniotic membrane:	n/a
27	chr5:1632226-1632276	ProgFib	skin:	n/a
28	chr5:1635186-1635236	IMR90	lung:	fetal
29	chr5:1634502-1634552	MCF-7	breast:	n/a
30	chr5:1635186-1635236	NH-A	brain:	n/a
31	chr5:1633907-1633957	SK-N-SH	brain:	n/a
32	chr5:1632226-1632276	AoSMC	blood vessel:	n/a
33	chr5:1633907-1633957	SKMC	muscle:	n/a
34	chr5:1633907-1633957	AG04450	lung:	fetal
35	chr5:1633907-1633957	HCPEpiC	choroid plexus:	n/a
36	chr5:1634460-1634510	Hepatocyte	liver:	n/a
37	chr5:1632226-1632276	AG04449	skin:	fetal
38	chr5:1633907-1633957	NHDF-neo	bronchial:	n/a
39	chr5:1634505-1634555	H1-hESC	embryonic stem cell:	embryo
40	chr5:1634460-1634510	SK-N-SH	brain:	n/a
41	chr5:1634460-1634510	BE2_C	brain:	n/a
42	chr5:1634049-1634099	HMEC	breast:	n/a
43	chr5:1634460-1634510	GM06990	blood:	n/a
44	chr5:1634218-1634268	AoSMC	blood vessel:	n/a
45	chr5:1633398-1633448	AG04449	skin:	fetal
46	chr5:1635186-1635236	HRPEpiC	eye:	n/a
47	chr5:1634460-1634510	HL-60	blood:	n/a
48	chr5:1635186-1635236	GM12892	blood:	n/a
49	chr5:1633830-1633880	HCM	heart:	n/a
50	chr5:1634460-1634510	Jurkat	blood:	n/a

(count:13 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr12:52596128..52598397-chr5:1635134..1637588,2	MCF-7	breast:
2	chr5:271248..271771-chr5:1634015..1634576,2	Hela-S3	cervix:
3	chr5:1524111..1525678-chr5:1634635..1636646,2	K562	blood:
4	chr17:7387515..7388140-chr5:1634106..1634629,2	Hela-S3	cervix:
5	chr5:1347764..1350129-chr5:1631038..1633995,2	K562	blood:
6	chr2:220549582..220550397-chr5:1633906..1634538,2	HCT-116	colon:
7	chr13:76334345..76334921-chr5:1633791..1634398,2	Hela-S3	cervix:
8	chr11:18548173..18549021-chr5:1633797..1634587,2	Hela-S3	cervix:
9	chr3:169482234..169483056-chr5:1633603..1634536,2	Hela-S3	cervix:
10	chr15:60690446..60691098-chr5:1633940..1634587,2	Hela-S3	cervix:
11	chr5:1632420..1636449-chr5:1636560..1641821,6	MCF-7	breast:
12	chr2:99951914..99953131-chr5:1633620..1634641,3	Hela-S3	cervix:
13	chr5:1633756..1634705-chr6:27100367..27101254,2	Hela-S3	cervix:

(count:1 , 50 per page) page: 1

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-LPCAT1-3	chr5:1632759-1632796	NONHSAT147316

No data

Variant related genes	Relation type
ENSG00000188002	TF binding region
ENSG00000188002	CpG island
ENSG00000182718	chromatin interactions
ENSG00000196787	chromatin interactions
ENSG00000248925	chromatin interactions
ENSG00000124635	chromatin interactions
ENSG00000270141	chromatin interactions
ENSG00000181222	chromatin interactions
ENSG00000174282	chromatin interactions
ENSG00000249915	chromatin interactions
ENSG00000227308	chromatin interactions
ENSG00000074319	chromatin interactions
ENSG00000115514	chromatin interactions
ENSG00000188002	chromatin interactions
ENSG00000136153	chromatin interactions

Extended variants
information (count: 250 )
Associated
traits (count: 113 )

Variant overlapped rSNPs/rCNVs (count:250 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs188866460	chr5:1631521-1631522	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs535651709	chr5:1631553-1631554	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs555738024	chr5:1631561-1631562	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs77354642	chr5:1631645-1631646	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs140589129	chr5:1631650-1631651	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs544618727	chr5:1631652-1631653	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs72719204	chr5:1631655-1631656	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs560810325	chr5:1631675-1631676	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs374854686	chr5:1631719-1631720	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs528003642	chr5:1631751-1631752	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs112806128	chr5:1631767-1631768	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs200728509	chr5:1631777-1631778	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs112260934	chr5:1631778-1631779	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs561360212	chr5:1631797-1631798	Weak transcription Strong transcription Enhancers Genic enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs372939204	chr5:1631801-1631802	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
16	rs369256812	chr5:1631802-1631803	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
17	rs62335920	chr5:1631807-1631808	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
18	rs372043970	chr5:1631823-1631824	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
19	rs147792395	chr5:1631829-1631830	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
20	rs113351525	chr5:1631851-1631852	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
21	rs141279231	chr5:1631870-1631871	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
22	rs59606006	chr5:1631873-1631874	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
23	rs149627154	chr5:1631895-1631896	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
24	rs62335921	chr5:1631896-1631897	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
25	rs571781639	chr5:1631902-1631903	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
26	rs376953862	chr5:1631926-1631927	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
27	rs4975675	chr5:1631932-1631933	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
28	rs547498773	chr5:1631949-1631950	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
29	rs138654114	chr5:1631961-1631962	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
30	rs566737777	chr5:1631967-1631968	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
31	rs201163491	chr5:1631969-1631970	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
32	rs564098506	chr5:1631984-1631985	Weak transcription Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
33	rs573172207	chr5:1632001-1632002	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
34	rs148379330	chr5:1632015-1632016	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
35	rs555530015	chr5:1632039-1632040	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
36	rs56801373	chr5:1632040-1632041	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
37	rs371562496	chr5:1632063-1632064	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
38	rs573257079	chr5:1632064-1632065	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
39	rs56861970	chr5:1632070-1632071	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
40	rs200173441	chr5:1632071-1632072	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
41	rs6861928	chr5:1632134-1632135	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
42	rs555805335	chr5:1632181-1632182	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
43	rs10051495	chr5:1632186-1632187	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	mRNA abundance
44	rs59152371	chr5:1632188-1632189	Weak transcription Active TSS Enhancers Flanking Active TSS	n/a	n/a	Overlapped CNVs	n/a
45	rs185444754	chr5:1632226-1632227	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs142744924	chr5:1632247-1632248	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs577401765	chr5:1632264-1632265	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs6891307	chr5:1632266-1632267	Weak transcription Active TSS Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
49	rs150756480	chr5:1632273-1632274	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs139121246	chr5:1632300-1632301	Weak transcription Active TSS Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:113)

Disease	PMID	Source
Biliary cancer	19435499	CNVD
Myelofibrosis	22110671	CNVD
Breast cancer	16608533	CNVD
Cervical cancer	16585170	CNVD
Glioblastoma multiforme	22286061	CNVD
Lung cancer	17925434	CNVD
Ovarian cancer	20844748	CNVD
Cervical squamous cell carcinoma	21590768	CNVD
Non-small cell lung cancer	21829676	CNVD
Intracranial ependymoma	16609018	CNVD
Breast cancer	19181860	CNVD
prenatal diagnosis	20453657	CNVD
Developmental delay	19490664	CNVD
Human papillomavirus	17975027	CNVD
Acute monocytic leukemia	16498392	CNVD
Gastric cancer	16891809	CNVD
Intracranial aneurysm	16715129	CNVD
Emphysema	19352772	CNVD
Chordoma	18071362	CNVD
Esophageal squamous carcinoma	18405350	CNVD
Lung cancer	21911935	CNVD
Cri-du chat syndrome	21549014	CNVD
Melanoma	18172304	CNVD
Non-syndromic sensorineural hearing loss	20606397	CNVD
Sudden cardiac death	19188705	CNVD
renal disease	17924346	CNVD
abnormal development	18461090	CNVD
Lung cancer	19547694	CNVD
Cri-du chat syndrome	22283845	CNVD
Disorders of sex development	21048976	CNVD
Non-small cell lung cancer	20864512	CNVD
Cancer	21183584	CNVD
Honadal dysgenesis	21048976	CNVD
Cancer	16751803	CNVD
Breast cancer	17133270	CNVD
Hepatocellular carcinoma	22174799	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Salivary gland tumor	18059337	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Kartagener syndrome	16639409	CNVD
Medulloblastoma	21979893	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	21080181	CNVD
Medulloblastoma	16783165	CNVD
Thyroid cancer	19087340	CNVD
Liposarcoma	21253554	CNVD
Pancreatic endocrine tumor	17639061	CNVD
Cervical Cancer	21857958	CNVD
Cervical cancer	21062161	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	19960244	CNVD
Oral cancer	21386901	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Ewing''s sarcoma	17952124	CNVD
Malignant mesothelioma	18160781	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Cervical cancer	18559093	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Metanephric adenoma	20802469	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Gastrointestinal stromal cancer	16982739	CNVD
Phyllodes tumor	17334353	CNVD
Malaria	21533027	CNVD
Renal cell carcinoma	19461508	CNVD
Colorectal cancer	21645411	CNVD
Gastric cancer	22152101	CNVD
Oesophago-gastric ulcer	22152101	CNVD
Ovarian cancer	21781307	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	21509527	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	21364760	CNVD
Cancer	20164919	CNVD
Oral cancer	22144094	CNVD
Non-syndromic sensorineural hearing loss	18496225	CNVD
Urothelial carcinoma	21177765	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Thoracic aortic aneurysm	21092924	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Multiple myeloma	17550852	CNVD
Pleomorphic liposarcoma	18784837	CNVD
Developmental delay	21147756	CNVD
prenatal diagnosis	22389664	CNVD
Bladder cancer	21909424	CNVD
DNA damage stimulus	22844521	CNVD
DNA repair	22844521	CNVD
Breast cancer	21785460	CNVD
Spinal muscular atrophy	22422766	CNVD
Spinal muscular atrophy	22558076	CNVD
Spinal muscular atrophy	21320981	CNVD
Spinal muscular atrophy	21762474	CNVD
Breast cancer	21858162	CNVD
Prostate cancer	18632612	CNVD
Esophageal adenocarcinoma	19417022	CNVD
Melanoma	22183965	CNVD
small cell lung cancer	20016488	CNVD
Lung cancer	18438408	CNVD
XY gonadal dysgenesis	20685758	CNVD
lymphocytic leukemia	21291569	CNVD
Autism	22495311	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:441 , 50 per page) page: 1 2 3 4 5 6 7 ... 9

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr5:1595000-1634000	Weak transcription	Stomach Mucosa	stomach
2	chr5:1595200-1632800	Weak transcription	Brain Angular Gyrus	brain
3	chr5:1595200-1632800	Weak transcription	Right Ventricle	heart
4	chr5:1595400-1633200	Weak transcription	Primary B cells from cord blood	blood
5	chr5:1595400-1633200	Weak transcription	Brain Cingulate Gyrus	brain
6	chr5:1595400-1633200	Weak transcription	Duodenum Smooth Muscle	Duodenum
7	chr5:1595400-1633200	Weak transcription	Rectal Mucosa Donor 31	rectum
8	chr5:1597600-1632600	Weak transcription	Brain Dorsolateral Prefrontal Cortex	brain
9	chr5:1597600-1632800	Weak transcription	Rectal Mucosa Donor 29	rectum
10	chr5:1597600-1632800	Weak transcription	Rectal Smooth Muscle	rectum
11	chr5:1597600-1633000	Weak transcription	Brain Hippocampus Middle	brain
12	chr5:1601400-1632800	Weak transcription	Hela-S3	cervix
13	chr5:1606200-1633200	Weak transcription	Brain Anterior Caudate	brain
14	chr5:1608800-1632800	Weak transcription	Skeletal Muscle Female	skeletal muscle
15	chr5:1608800-1633800	Weak transcription	Fetal Lung	lung
16	chr5:1609200-1633200	Weak transcription	Primary T helper cells PMA-I stimulated	--
17	chr5:1609200-1633200	Weak transcription	Primary T helper 17 cells PMA-I stimulated	--
18	chr5:1609600-1633600	Weak transcription	Left Ventricle	heart
19	chr5:1610000-1633400	Weak transcription	Colonic Mucosa	Colon
20	chr5:1610600-1632800	Weak transcription	NHEK	skin
21	chr5:1610600-1633200	Weak transcription	Colon Smooth Muscle	Colon
22	chr5:1611800-1633800	Weak transcription	Placenta Amnion	Placenta Amnion
23	chr5:1613200-1633200	Weak transcription	HSMMtube	muscle
24	chr5:1613800-1633800	Weak transcription	Primary T cells effector/memory enriched fromperipheralblood	blood
25	chr5:1617000-1633200	Weak transcription	Muscle Satellite Cultured Cells	--
26	chr5:1617400-1632600	Weak transcription	Primary T regulatory cells fromperipheralblood	blood
27	chr5:1617400-1633200	Weak transcription	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
28	chr5:1619000-1633200	Weak transcription	Foreskin Keratinocyte Primary Cells skin02	Skin
29	chr5:1619400-1632800	Weak transcription	Skeletal Muscle Male	skeletal muscle
30	chr5:1619400-1633800	Weak transcription	Primary monocytes fromperipheralblood	blood
31	chr5:1619600-1632400	Weak transcription	Primary T cells fromperipheralblood	blood
32	chr5:1619600-1632800	Weak transcription	GM12878-XiMat	blood
33	chr5:1619600-1633000	Weak transcription	Foreskin Keratinocyte Primary Cells skin03	Skin
34	chr5:1619600-1633800	Weak transcription	Placenta	Placenta
35	chr5:1620000-1633800	Weak transcription	Lung	lung
36	chr5:1620400-1633800	Weak transcription	Primary T helper memory cells from peripheral blood 2	blood
37	chr5:1621600-1633200	Weak transcription	hESC Derived CD56+ Ectoderm Cultured Cells	ES cell derived
38	chr5:1621600-1633200	Weak transcription	Primary T helper naive cells fromperipheralblood	blood
39	chr5:1621800-1632800	Weak transcription	Primary B cells from peripheral blood	blood
40	chr5:1622000-1633200	Weak transcription	Duodenum Mucosa	Duodenum
41	chr5:1622200-1633800	Weak transcription	Fetal Kidney	kidney
42	chr5:1622600-1632800	Weak transcription	Foreskin Fibroblast Primary Cells skin02	Skin
43	chr5:1623200-1633200	Weak transcription	iPS DF 6.9 Cell Line	embryonic stem cell
44	chr5:1623400-1633800	Weak transcription	Primary T cells from cord blood	blood
45	chr5:1624200-1633200	Weak transcription	iPS-18 Cell Line	embryonic stem cell
46	chr5:1624400-1632800	Weak transcription	iPS-20b Cell Line	embryonic stem cell
47	chr5:1624400-1633200	Weak transcription	H1 Cell Line	embryonic stem cell
48	chr5:1624400-1633200	Weak transcription	HUES48 Cell Line	embryonic stem cell
49	chr5:1624600-1632800	Weak transcription	HUES6 Cell Line	embryonic stem cell
50	chr5:1625000-1632000	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links